Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
SGIOY Quote, Financials, Valuation and Earnings
Last price:
$8.44
Seasonality move
:
6.6%
Day range:
$8.32 - $8.39
52-week range:
$6.53 - $8.99
Dividend yield:
2.48%
P/E ratio:
18.72x
P/S ratio:
9.76x
P/B ratio:
1.56x
Volume:
97.3K
Avg. volume:
77.3K
1-year change:
20.2%
Market cap:
$14.2B
Revenue:
$2.9B
EPS (TTM):
$0.45
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Shionogi & has -- downside to fair value with a price target of -- per share.
SGIOY vs. S&P 500
-
Over the past 5 trading days, Shionogi & has underperformed the S&P 500 by -0.86% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Shionogi & does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Shionogi & revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Shionogi & reported revenues of $784.3M.
Earnings Growth
-
Shionogi & has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Shionogi & reported earnings per share of $0.20.
Enterprise value:
9.9B
EV / Invested capital:
--
Price / LTM sales:
9.76x
EV / EBIT:
7.11x
EV / Revenue:
3.40x
PEG ratio (5yr expected):
--
EV / Free cash flow:
11.05x
Price / Operating cash flow:
15.42x
Enterprise value / EBITDA:
6.46x
Gross Profit (TTM):
$2.5B
Return On Assets:
11.07%
Net Income Margin (TTM):
38.89%
Return On Equity:
12.6%
Return On Invested Capital:
12.39%
Operating Margin:
44.6%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.5B | $3B | $3B | $719.8M | $784.3M | |
| Gross Profit | $3B | $2.6B | $2.6B | $621.5M | $680.1M | |
| Operating Income | $1.5B | $990.5M | $1.1B | $275.2M | $349.8M | |
| EBITDA | $2B | $1.5B | $1.6B | $383.1M | $447.3M | |
| Diluted EPS | $0.85 | $0.63 | $0.67 | $0.14 | $0.20 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5B | $5.4B | $5.9B | $5.2B | $5.7B | |
| Total Assets | $9.1B | $9.4B | $9.8B | $9.4B | $10.3B | |
| Current Liabilities | $908.1M | $1B | $1.2B | $884.7M | $864.7M | |
| Total Liabilities | $1.2B | $1.3B | $1.4B | $1.1B | $1.2B | |
| Total Equity | $7.8B | $8.1B | $8.4B | $8.3B | $9.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $909.2M | $1.3B | $1.1B | $491.7M | $615M | |
| Cash From Investing | -$856.9M | -$357.6M | $41M | $204.8M | $109.8M | |
| Cash From Financing | -$326.2M | -$623M | -$879.1M | -$29.8M | -$244.9M | |
| Free Cash Flow | $628M | $1B | $873.3M | $460.9M | $563.2M | |
SGIOY
Sector
Market Cap
$14.2B
$34.4M
Price % of 52-Week High
92.88%
48.88%
Dividend Yield
2.48%
0%
Shareholder Yield
7.41%
-1.01%
1-Year Price Total Return
20.2%
-37.36%
Beta (5-Year)
0.254
0.614
Dividend yield:
2.48%
Annualized payout:
$0.21
Payout ratio:
--
Growth streak:
3 years
Technicals
8-day SMA
Sell
Level
$8.37
200-day SMA
Buy
Level
$7.55
Bollinger Bands (100)
Buy
Level
7.64 - 8.5
Chaikin Money Flow
Buy
Level
219.8K
20-day SMA
Sell
Level
$8.57
Relative Strength Index (RSI14)
Sell
Level
44.79
ADX Line
Sell
Level
11.01
Williams %R
Neutral
Level
-71.9101
50-day SMA
Buy
Level
$8.33
MACD (12, 26)
Buy
Level
2.28
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Sell
Level
-22.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.9383)
Buy
CA Score
(Annual)
Level (2.026)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-5.866)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.
Stock Forecast FAQ
In the current month, SGIOY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SGIOY average analyst price target in the past 3 months is --.
-
Where Will Shionogi & Stock Be In 1 Year?
According to analysts, the consensus estimate is that Shionogi & share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Shionogi &?
Analysts are divided on their view about Shionogi & share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Shionogi & is a Sell and believe this share price will rise from its current level to --.
-
What Is Shionogi &'s Price Target?
The price target for Shionogi & over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SGIOY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Shionogi & is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SGIOY?
You can purchase shares of Shionogi & via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Shionogi & shares.
-
What Is The Shionogi & Share Price Today?
Shionogi & was last trading at $8.44 per share. This represents the most recent stock quote for Shionogi &. Yesterday, Shionogi & closed at $8.35 per share.
-
How To Buy Shionogi & Stock Online?
In order to purchase Shionogi & stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
